about
Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' allelesDevelopment of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.Protein arrays and pattern recognition: new tools to assist in the identification and management of autoimmune disease.Use of REMEDi HS in emergency toxicology for a rapid estimate of drug concentrations in urine, serum, and gastric samples.Detection of immunoglobulin M antibodies specific for Toxoplasma gondii with increased selectivity for recently acquired infections.ANA testing in the presence of acute and chronic infections.Anti-phospholipid Antibodies and Smoking: An Overview.The development of a broad-spectrum toxicology screening program in Taiwan.Analysis of drugs of abuse in biological fluids by liquid chromatography.Standardization of a multi-wavelength UV detector for liquid chromatography-based toxicological analysisAnalysis of urinary catecholamines by high-performance liquid chromatography in the presence of labetalol metabolitesAnalysis of benzodiazepines and tricyclic antidepressants in serum using a common solid-phase clean-up and a common mobile phaseAutomated liquid chromatographic analysis of drugs in urine by on-line sample cleanup and isocratic multi-column separationPediatric reference intervals for normetanephrine/metanephrineQuantitation of urinary normetanephrine and metanephrine by reversed-phase extraction and mass-fragmentographic analysisMeasurement of urinary vanilmandelic acid and homovanillic acid by high-performance liquid chromatography with electrochemical detection following extraction by ion-exchange and ion-moderated partitionEvaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodiesAssociation between systemic lupus erythematosus and Helicobacter pylori seronegativityDevelopment of monoclonal antibodies to pre-haptoglobin 2 and their use in an enzyme-linked immunosorbent assay (ELISA)A novel algorithm to improve specificity in ovarian cancer detection
P50
Q35136055-BA794998-CF22-4C96-A29A-4D296E14FEBCQ36297670-97B46F09-AE87-41DB-8147-A24C66ED0F08Q36477558-6B2E6E77-BC25-4658-AC2B-C7283887CF33Q36817651-84D3F69A-15F0-4389-A6D1-69FEEB9EC20BQ37702723-41EA4DD2-DEB9-459A-930D-EC2E87A30322Q38799673-D14455BA-6C6C-4A05-8022-4686769227A3Q38885685-452F90E8-D41A-493B-8D2E-E52407C65454Q39416373-CCB4352D-ABE4-4B2D-B4B6-8C5CD206D78FQ40934079-0DEC69AB-99DB-4B0F-9FCB-55A26A26F8BDQ67827916-A8C68FF0-36C1-414A-AAD4-647AA0C95E54Q68963154-34E166B6-0904-4F02-8411-CBB4DE87EBA0Q69378748-5A22C246-B72E-4BDE-B7AC-7D31B3974400Q69700380-2BFA493D-B590-458C-9B5D-1AC6B4A7AA65Q70117901-C401CC28-DA21-408C-AF66-D72487BA2988Q70271439-2433389E-D0B5-4BFA-8026-4145AA31198FQ70756234-C1CB9F61-A578-4D61-965D-09A2427D9137Q80367302-42DD8D5D-5C6E-46FE-9212-031F3DD076D0Q80410601-C5D07A6F-6B2A-4DB8-8B54-D833CFB4E5FBQ87385686-4BAE4C86-2A7E-47F1-A5CF-199EB12F20F4Q91399349-62BE5DEB-807A-499C-8AC5-30B81084FF41
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Steven R Binder
@ast
Steven R Binder
@en
Steven R Binder
@es
Steven R Binder
@nl
type
label
Steven R Binder
@ast
Steven R Binder
@en
Steven R Binder
@es
Steven R Binder
@nl
prefLabel
Steven R Binder
@ast
Steven R Binder
@en
Steven R Binder
@es
Steven R Binder
@nl
P106
P1153
7102744620
P31
P496
0000-0003-4091-2090